Gehring Gerrit, Rohrmann Katrin, Atenchong Nkacheh, Mittler Eva, Becker Stephan, Dahlmann Franziska, Pöhlmann Stefan, Vondran Florian W R, David Sascha, Manns Michael P, Ciesek Sandra, von Hahn Thomas
Institute for Molecular Biology, Hannover Medical School, Hannover, Germany Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Institute for Molecular Biology, Hannover Medical School, Hannover, Germany.
J Antimicrob Chemother. 2014 Aug;69(8):2123-31. doi: 10.1093/jac/dku091. Epub 2014 Apr 7.
Filoviruses such as Ebola virus and Marburg virus cause a severe haemorrhagic fever syndrome in humans for which there is no specific treatment. Since filoviruses use a complex route of cell entry that depends on numerous cellular factors, we hypothesized that there may be drugs already approved for human use for other indications that interfere with signal transduction or other cellular processes required for their entry and hence have anti-filoviral properties.
We used authentic filoviruses and lentiviral particles pseudotyped with filoviral glycoproteins to identify and characterize such compounds.
We discovered that amiodarone, a multi-ion channel inhibitor and adrenoceptor antagonist, is a potent inhibitor of filovirus cell entry at concentrations that are routinely reached in human serum during anti-arrhythmic therapy. A similar effect was observed with the amiodarone-related agent dronedarone and the L-type calcium channel blocker verapamil. Inhibition by amiodarone was concentration dependent and similarly affected pseudoviruses as well as authentic filoviruses. Inhibition of filovirus entry was observed with most but not all cell types tested and was accentuated by the pre-treatment of cells, indicating a host cell-directed mechanism of action. The New World arenavirus Guanarito was also inhibited by amiodarone while the Old World arenavirus Lassa and members of the Rhabdoviridae (vesicular stomatitis virus) and Bunyaviridae (Hantaan) families were largely resistant.
The ion channel blockers amiodarone, dronedarone and verapamil inhibit filoviral cell entry.
埃博拉病毒和马尔堡病毒等丝状病毒可导致人类严重出血热综合征,目前尚无特效治疗方法。由于丝状病毒采用复杂的细胞进入途径,依赖众多细胞因子,我们推测可能存在已获批准用于其他适应症的人类用药,这些药物可干扰其进入所需的信号转导或其他细胞过程,因而具有抗丝状病毒特性。
我们使用正宗丝状病毒和用丝状病毒糖蛋白假型化的慢病毒颗粒来鉴定和表征此类化合物。
我们发现,胺碘酮,一种多离子通道抑制剂和肾上腺素能受体拮抗剂,在抗心律失常治疗期间人体血清中通常达到的浓度下,是丝状病毒细胞进入的有效抑制剂。与胺碘酮相关的药物决奈达隆和L型钙通道阻滞剂维拉帕米也观察到类似效果。胺碘酮的抑制作用呈浓度依赖性,对假病毒和正宗丝状病毒的影响相似。在大多数但并非所有测试的细胞类型中均观察到丝状病毒进入的抑制作用,并且细胞预处理会增强这种抑制作用,表明其作用机制是针对宿主细胞的。新世界沙粒病毒瓜纳里托也受到胺碘酮的抑制,而旧世界沙粒病毒拉沙病毒以及弹状病毒科(水疱性口炎病毒)和布尼亚病毒科(汉坦病毒)的成员大多具有抗性。
离子通道阻滞剂胺碘酮、决奈达隆和维拉帕米可抑制丝状病毒的细胞进入。